Finally, despite a low relative proportion of CD8+ T cells, the CD4+/CD8+ T cell ratio was found at the highest amplitude in the mrHCC2 subgroup, confirming previous studies where a similar trend was observed only in patients with HCC who had better prognosis50, 51. This evidence concerns the gene CD4 and hepatocellular carcinoma.